Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 4,178 recruiting studies in this area right now.
By phase
- Not applicable2,713
- Phase 2361
- Phase 4321
- Phase 1290
- Phase 3288
- Phase 1/Phase 2141
- Phase 2/Phase 364
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris80
- University of California, San Francisco44
- Johns Hopkins University31
- Hospices Civils de Lyon30
- National Cancer Institute (NCI)28
- University of Washington27
- University Hospital, Strasbourg, France26
- Columbia University23
- University of Alabama at Birmingham23
Where studies are running
- California235
- Maryland146
- Alabama89
- New York76
- Florida74
- Texas61
- Massachusetts56
- Arizona47
- Pennsylvania45
- Illinois42
Recruiting studies4,178 total
- NCT06829719Recruiting
Using TTV virus to manage immune drugs in kidney transplant
This trial uses a virus called TTV to see if it can help doctors safely adjust immunosuppression drugs in kidney transplant patients. It aims to find a way to lower the risk of rejection while reducing side effects.
Bordeaux (France)Ages 18 years+ - NCT06832436Recruiting
Atrial strain study in septic shock patients
This study looks at how well the upper chambers of the heart (atria) work during septic shock using a special heart ultrasound. It may help doctors understand how the heart is affected by severe infections.
SalouëlAges 18 years+ - NCT06833957Recruiting
Preparing for a maternal GBS vaccine in Africa
This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.
Mariakani, CoastAges Any age - NCT06834100RecruitingPhase 3
Comparing a new meningitis vaccine to an approved one
This trial tests a new meningitis vaccine (GNG-DE) to see how well it works compared to a vaccine already on the market. It might help protect you or your child from meningococcal disease.
KirovAges 3–55 - NCT06834178Recruiting
Counting undiagnosed hepatitis B, C and D in Austria
This study is looking for people in south-east Austria who have hepatitis B (HBV) or hepatitis C (HCV) that hasn't been fully treated or documented. It aims to find how many people also have hepatitis D (HDV) and are not yet aware of it.
Graz, StyraAges Any age - NCT06834971Recruiting
Inhaled colistin to prevent pneumonia in ventilated patients
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
Jinan, ShandongAges 18 years+ - NCT06835361RecruitingPhase 2/Phase 3
Comparing two yeast infection treatments for women
This trial tests if a new combination vaginal suppository works better than the standard one for women with yeast infections. It aims to see if adding lactulose to clotrimazole helps clear the infection faster or more completely.
Minsk, Minsk CityAges 18–60 - NCT06835842Recruiting
Rib mobilization for pneumonia patients on a ventilator
This study tests whether a gentle rib movement technique (called rib mobilization) can help people with pneumonia who are on a breathing machine get ready to breathe on their own. It aims to see if this therapy makes it easier to wean off the ventilator.
CairoAges 40–50 - NCT06838598Recruiting
Studying biofilm on arterial catheters in the ICU
This study looks at the buildup of bacteria on arterial catheters (thin tubes placed in an artery) used in intensive care. By understanding these biofilms, doctors may find better ways to prevent infections.
Dijon, Bourgogne-Franche-ComtéAges 18 years+ - NCT06840860Recruiting
EPIC study: testing for VMPX
This study tests people for VMPX to learn more about the condition and to understand how it affects the body. You can join if you are willing to be tested and can give permission.
Kinshasa, MasinaAges Any age - NCT06841237Recruiting
Ointment for diabetic foot ulcer healing
This study tests whether a traditional Chinese ointment (Xiang Lei) can help heal diabetic foot ulcers. It is for people with diabetes who have a wound that is already starting to heal (granulation phase) and whose blood sugar is well-controlled.
Beijing, Beijing MunicipalityAges 18–80 - NCT06841913RecruitingPhase 4
Woodsmoke, flu, and your nasal immune response
This study tests how breathing woodsmoke affects your nose's ability to fight off the flu virus. You will be exposed to woodsmoke and then given a live flu vaccine to see how your immune system responds.
Chapel Hill, North CarolinaAges 18–49 - NCT06842173RecruitingPhase 1/Phase 2
Safety testing of new bird flu vaccine (H5N8) in adults
This trial tests a new bird flu (H5N8) vaccine for adults aged 18 and older. It looks at how safe the vaccine is and how well it triggers an immune response. The vaccine is given as a shot and includes an adjuvant to boost protection.
Belo Horizonte, Minas GeraisAges 18 years+ - NCT06843018RecruitingPhase 2
Spray vs lozenge for sore throat from infection
This trial tests a new spray with anesthetic for sore throat caused by infections like pharyngitis. It compares the spray to a lozenge (Septolete Total) to see which works better and is safer.
Engel'sAges 18–75 - NCT06843226Recruiting
Dengue vaccine study for children and teens
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
Banjarmasin, South KalimantanAges 6–12 - NCT06843317RecruitingPhase 1
RSV vaccine booster for older adults
This trial tests a booster dose of an experimental RSV vaccine (SCB-1019T) in healthy adults aged 60-85 who have already received the approved RSV vaccine AREXVY. The goal is to see if the booster is safe and boosts your immune system.
Phoenix, ArizonaAges 60–85 - NCT06844045Recruiting
Point-of-care STI testing for young adults
This trial is testing a quick, point-of-care test for chlamydia and gonorrhea in young people aged 16-24. It aims to make STI testing faster and easier right where you get care.
Philadelphia, PennsylvaniaAges 16–24 - NCT06845618Recruiting
Blood test to monitor tuberculosis treatment
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
TakAges 18 years+ - NCT06847126RecruitingPhase 3
Oral vs IV antibiotics for liver abscess treatment
This trial compares two antibiotic treatments for liver abscess: one given through an IV (into a vein) and one taken as pills by mouth. The goal is to see if the oral treatment works just as well, which could make treatment easier and more convenient for patients.
ChandigarhAges 18 years+ - NCT06848309Recruiting
Immune response study for influenza or COVID-19
This study looks at how your immune system fights off flu or COVID-19. If you have a current or recent infection, or if you've been vaccinated in the past year, you may be able to join.
St Louis, MissouriAges 18–60 - NCT06848387RecruitingPhase 4
Cloxacillin levels during continuous infusion
This trial measures how the body processes cloxacillin when it's given as a continuous infusion for infections. If you're already receiving this treatment, the results may help doctors optimize your dose.
VästeråsAges 18 years+ - NCT06850298Recruiting
H5N1 milk detection study
This study looks for the H5N1 virus in the milk of healthy adults. If you are generally healthy and between 18 and 64, you may be able to help by providing milk samples to see if the virus can be detected.
Atlanta, GeorgiaAges 18–64 - NCT06850350Recruiting
Long COVID and Thinking & Walking
This study looks at how Long COVID affects thinking and movement skills. If you had COVID-19 more than 3 months ago and could walk before you got sick, you may be able to help researchers understand these lasting symptoms.
Chicago, IllinoisAges 18 years+ - NCT06853184RecruitingPhase 2
Artesunate for CMV in transplant patients
This trial tests a study drug called artesunate as a possible new treatment for CMV (a common virus) in people who have had a kidney, lung, heart, or liver transplant. It is for patients whose CMV infection requires treatment with standard antivirals like ganciclovir or valganciclovir.
Boston, MassachusettsAges 18 years+
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 4,178 recruiting infectious disease studies from the U.S. registry right now, out of 7,113 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.